Alzheimer's disease vaccine oral/nasal - Harvard Medical School
Latest Information Update: 25 Aug 2006
Price :
$50 *
At a glance
- Originator Harvard Medical School
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 25 Aug 2006 No development reported - Preclinical for Alzheimer's disease in USA (Intranasal)
- 25 Aug 2006 No development reported - Preclinical for Alzheimer's disease in USA (PO)
- 29 Jan 2002 Preclinical development for Alzheimer's disease in USA (Intranasal)